12/19
04:17 pm
lfcr
Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025 [Yahoo! Finance]
Low
Report
Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025 [Yahoo! Finance]
12/19
04:05 pm
lfcr
Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025
Low
Report
Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025
12/19
07:13 am
lfcr
Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment [Yahoo! Finance]
Low
Report
Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment [Yahoo! Finance]
12/19
07:00 am
lfcr
Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment
Low
Report
Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment
12/18
10:00 am
lfcr
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Medium
Report
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
12/15
10:00 am
lfcr
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation
Low
Report
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation
12/12
10:11 am
lfcr
Here's Why Arquitos Capital Management Largely Exited Lifecore (LFCR) [Yahoo! Finance]
Neutral
Report
Here's Why Arquitos Capital Management Largely Exited Lifecore (LFCR) [Yahoo! Finance]
12/11
03:00 pm
lfcr
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation
Low
Report
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation
11/26
04:14 pm
lfcr
Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO [Yahoo! Finance]
Low
Report
Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO [Yahoo! Finance]
11/26
04:05 pm
lfcr
Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO
Low
Report
Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO
11/22
12:19 pm
lfcr
Lifecore Biomedical, Inc. (NASDAQ: LFCR) had its price target raised by analysts at Craig Hallum from $8.00 to $10.00. They now have a "buy" rating on the stock.
Low
Report
Lifecore Biomedical, Inc. (NASDAQ: LFCR) had its price target raised by analysts at Craig Hallum from $8.00 to $10.00. They now have a "buy" rating on the stock.
11/21
04:22 pm
lfcr
Lifecore Biomedical Hosts Virtual Investor Day [Yahoo! Finance]
Medium
Report
Lifecore Biomedical Hosts Virtual Investor Day [Yahoo! Finance]
11/21
04:17 pm
lfcr
Lifecore Biomedical Hosts Virtual Investor Day
High
Report
Lifecore Biomedical Hosts Virtual Investor Day
11/15
08:59 am
lfcr
Here's Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR) [Yahoo! Finance]
Medium
Report
Here's Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR) [Yahoo! Finance]
11/12
04:05 pm
lfcr
Lifecore Biomedical to Present at Stephens Annual Investment Conference
Low
Report
Lifecore Biomedical to Present at Stephens Annual Investment Conference
11/12
02:44 pm
lfcr
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) top owners are retail investors with 35% stake, while 35% is held by hedge funds [Yahoo! Finance]
Low
Report
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) top owners are retail investors with 35% stake, while 35% is held by hedge funds [Yahoo! Finance]
11/7
07:00 am
lfcr
Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024
Low
Report
Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024
11/4
07:00 am
lfcr
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
Low
Report
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
10/11
01:24 pm
lfcr
Lifecore Biomedical GAAP EPS of -$0.53, revenue of $24.7M [Seeking Alpha]
Low
Report
Lifecore Biomedical GAAP EPS of -$0.53, revenue of $24.7M [Seeking Alpha]
10/11
09:44 am
lfcr
Johnson Fistel LLP Investigates Lifecore Biomedical, Inc’s Directors and Officers for Breach of Fiduciary Duties and Encourages Long Term Shareholders to Reach Out for Their Options
Medium
Report
Johnson Fistel LLP Investigates Lifecore Biomedical, Inc’s Directors and Officers for Breach of Fiduciary Duties and Encourages Long Term Shareholders to Reach Out for Their Options
10/4
07:30 am
lfcr
Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update
High
Report
Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update
10/4
07:20 am
lfcr
Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock
High
Report
Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock
10/3
04:05 pm
lfcr
Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024
High
Report
Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024
10/1
07:00 am
lfcr
Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology
Low
Report
Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology
9/28
11:00 am
lfcr
The Schall Law Firm Encourages Investor Participation In A Securities Fraud Case Against Lifecore Biomedical Inc
Low
Report
The Schall Law Firm Encourages Investor Participation In A Securities Fraud Case Against Lifecore Biomedical Inc